Avidity Partners Management LP Mersana Therapeutics, Inc. Transaction History

Avidity Partners Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$3.08 - $9.55 $1.1 Million - $3.41 Million	356,767 Added 10.39%	3,790,000 $12.5 Million
Q1 2023 May 15, 2023	BUY	$4.0 - $7.02 $13.7 Million - $24.1 Million	3,433,233 New	3,433,233 $14.1 Million
Q4 2020 Feb 16, 2021	SELL	$16.84 - $27.59 $12.8 Million - $20.9 Million	-757,400 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$16.2 - $25.7 $5.06 Million - $8.02 Million	-312,200 Reduced 29.19%	757,400 $14.1 Million
Q2 2020 Aug 14, 2020	BUY	$5.24 - $23.4 $5.6 Million - $25 Million	1,069,600 New	1,069,600 $25 Million

121

116M

233K

457K

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $194M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

Stay updated on Avidity Partners Management LP with notifications on news.